Skip to main content
Figure 8 | BMC Cancer

Figure 8

From: Impact of diabetes type II and chronic inflammation on pancreatic cancer

Figure 8

Metformin reduces tumor weight and cancer cell proliferation. (A) 6606PDA cells were injected on day 0 into the pancreas of C57BL/6J mice. Between day 8 and day 29 PBS (Sham) or metformin was ip injected daily and tissue samples were analyzed on day 29. (B) Quantification of the tumor weight in the indicated mouse cohorts. (C) Quantification of BrdU+ nuclei within the carcinoma reveals that metformin treatment reduces cell proliferation. Box plots indicate the median, the 25th and 75th percentiles in the form of a box, and the 10th and 90th percentiles as whiskers. The number of animals evaluated was n = 8 (Sham) and n = 7 (metformin), Significant differences between the cohorts are indicated, *P = 0.004 (B), *P = 0.029 (C).

Back to article page